CPD accredited On Demand Webinars
ATTENTION! Kindly note that if you were in attendance of any of these live webinars, you have already received 1 CPD point and will not be permitted to receive additional points for the relevant on-demand report. Should this occur, the HPCSA will only record the 1 CPD point from the live webinar, invalidating any additional CPD points from the report. |

Clinical lunch chat series 2025
Held on Tuesday, 11 February, 25 February, 11 March, 25 March and 8 April 2025 with an unrestricted educational grant from Cipla
Join host, Dr Rust Theron, and expert guests, Prof Richard van Zyl Smit (Clinical lunch chat 1), Prof Piet Oosthuizen (Clinical lunch chat 2), Prof Erika Jones (Clinical lunch chat 2), Dr Hannes Koornhof (Clinical lunch chat 4) and Dr Margie Venter (Clinical lunch chat 5) as they answer your questions and provide you with valuable perspectives and actionable insights to modern clinical practice in each Clinical Lunch Chat session, available on-demand!

Rheumatology recap – Spotlight on new South African rheumatology guidelines
Held on Tuesday, 5 November 2024 with an unrestricted sponsorship from Aspen
New and updated treatment recommendations guide management of rheumatoid arthritis/spondyloarthritides in South African clinical practice: evidence-based interventions that provide holistic, quality care across all disease domains

Navigating the challenges of hypothyroidism management
Held on Wednesday, 23 October 2024 with an unrestricted sponsorship from Merck
Master the art of managing hypothyroidism! Navigate challenges to diagnosis, treatment approaches for primary/secondary disease, unpick causes of poor therapeutic response, understand the effects on fertility & comorbidities.

Rediscovering GIP – the overlooked hormone in type 2 diabetes mellitus
Held on Wednesday, 9 October 2024 with an unrestricted sponsorship from Aspen
Dr Hoosen Ahmed Randeree explains how targeting these incretins can provide effective strategies for managing Type 2 diabetes, particularly in patients with impaired β-cell function.

Clinical management of psoriatic arthritis and axial spondyloarthritis
Held on Wednesday, 25 September 2024 with an unrestricted sponsorship from Aspen
Innovation in spondyloarthritides therapy offers individualised management of the heterogeneous manifestations of this condition. Biologic disease-modifying therapies rapidly and significantly improve QoL and health outcomes

Clinical Lunch Chat series 2024
Held on Tuesday, 10 December, 26 November, 5 November, 22 October and 8 October 2024 with an unrestricted educational grant from Cipla
Join host, Physician, Dr Rust Theron, and expert guests, GP and Medical business adviser, Dr Tony Behrman, Endocrinologist, Dr Wayne May, Cardiologist, Dr Tony Dalby, Endocrinologist, Dr Wayne May, Urologist, Dr David Smart, and Clinical virologist, Prof Jean Maritz, as they answer your questions and provide you with valuable perspectives and actionable insights to modern clinical practice in each Clinical Lunch Chat session, available on-demand!

New horizons in ischaemic stroke management and prevention
Held on Tuesday, 5 November 2024 with an unrestricted educational grant from Cipla
Identify/manage risks for future stroke with the ESC integrated AF-CARE approach to comorbidities, anticoagulation, rate & rhythm control and re-evaluation, and the role of thrombectomy in acute ischaemic stroke

A multidisciplinary approach to treating plaque psoriasis
Held on Tuesday, 23 July 2024 with an unrestricted educational grant from Aspen
Ixekizumab provides early, sustained and complete skin clearance in moderate-to-severe psoriasis; learn more about assessing disease severity, treatment priorities, and how a holistic management approach improves quality of life.

Advances in asthma management – Strategies and innovations
Held on Thursday, 22 August 2024 with an unrestricted sponsorship from AstraZeneca
Poor asthma control is a primary care crisis, most asthma deaths are preventable. Learn about the consequences of SABA overuse/ICS underuse and how a SMART approach benefits patients irrespective of disease severity

CARE – The cardiovascular and diabetes forum for GPs
Event held Friday, 30 August to Sunday, 1 September 2024 with unrestricted sponsorship from Sanofi
Primary care priorities in diabetes include screening, diagnosis and approaches to glucose control and cardiovascular care; early treatment intensification and addressing of diabetes distress to optimise clinical outcomes and QoL

Impact of POPIA on ethical clinical practice today
Held on Wednesday, 12 June 2024 with an educational grant from Cipla
It is now four years since the POPIA came into full effect in South Africa and apparent real world clinical and ethical implications have emerged.

Stroke prevention in atrial fibrillation – How can we do better?
Held on Thursday, 19 March 2024 with an unrestricted educational grant from Sanofi
Dr Philasande Mkoko, cardiac electrophysiologist, Gauteng, provides clinical advice on optimal stroke protection in AF patients.

Bolstering early glycaemic control – Advances in diabetes care
Held on Saturday, 20 April 2024 with an unrestricted grant from Sanofi
This clinical review summarises the latest therapeutic and technological advances in the management of both Type 1 and Type 2 diabetes, their clinical progression, as well as a discourse on psychological aspects of these conditions

Breaking through the complexity of managing type 2 diabetes
Held on 30 August 2023, with an unrestricted educational grant from Sanofi
Three case studies are briefly presented and practical issues of intensification of glucose-lowering therapies tailored to the individual patient are illustrated in terms of good clinical practice